Evelina Tacconelli
#124,308
Most Influential Person Now
Evelina Tacconelli's AcademicInfluence.com Rankings
Evelina Tacconelliphilosophy Degrees
Philosophy
#5760
World Rank
#8653
Historical Rank
Logic
#2979
World Rank
#4067
Historical Rank

Download Badge
Philosophy
Evelina Tacconelli's Degrees
- PhD Public Health University of Oxford
Why Is Evelina Tacconelli Influential?
(Suggest an Edit or Addition)Evelina Tacconelli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Systematic reviews: CRD's guidance for undertaking reviews in health care (2010) (2717)
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) (2610)
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. (2014) (646)
- Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. (2010) (564)
- Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. (2018) (563)
- Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. (2017) (470)
- Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. (2007) (419)
- Combination therapy for carbapenem-resistant Gram-negative bacteria. (2014) (225)
- In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. (1999) (217)
- Monitoring approaches for health-care workers during the COVID-19 pandemic (2020) (199)
- Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. (2006) (188)
- Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. (2012) (185)
- Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. (2003) (182)
- Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control (2017) (178)
- Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. (2007) (176)
- Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and duration of hospital stay. (2006) (175)
- Surveillance for control of antimicrobial resistance. (2017) (166)
- Critical analysis of antibacterial agents in clinical development (2020) (147)
- Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. (1999) (146)
- Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. (2004) (141)
- Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. (2009) (140)
- Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. (2009) (138)
- Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings (2009) (137)
- Vancomycin-resistant enterococci (VRE): transmission and control. (2008) (136)
- Antibiotic Usage and Risk of Colonization and Infection with Antibiotic-Resistant Bacteria: a Hospital Population-Based Study (2009) (131)
- The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study (2016) (131)
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
- European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM –European Society of intensive care Medicine) (2021) (124)
- Prosthetic joint infection: recent developments in diagnosis and management. (2010) (116)
- Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia (2020) (112)
- Public health burden of antimicrobial resistance in Europe. (2019) (104)
- The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. (1995) (101)
- Multidrug-Resistant Pseudomonas Aeruginosa Bloodstream Infections: Analysis of Trends in Prevalence and Epidemiology (2002) (98)
- Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. (2014) (96)
- Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. (2014) (91)
- The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance. (2016) (91)
- Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators. (1998) (89)
- Gender differences in antibiotic prescribing in the community: a systematic review and meta-analysis. (2016) (87)
- Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (2020) (87)
- ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers. (2019) (85)
- Deciphering the state of immune silence in fatal COVID-19 patients (2020) (83)
- Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. (2002) (81)
- Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors. (2016) (78)
- Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. (2002) (77)
- Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving Highly Active Anti Retroviral Therapy (2004) (77)
- Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. (2003) (76)
- Prediction of bacteremia using TREAT, a computerized decision-support system. (2006) (76)
- Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. (2018) (73)
- Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario (2003) (68)
- In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli (2012) (68)
- The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. (2013) (67)
- Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. (2004) (66)
- Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans. (2017) (65)
- Epidemiology and genetic characteristics of extended-spectrum β-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. (2012) (65)
- Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries. (2015) (64)
- Central venous catheter-related sepsis in a cohort of 366 hospitalised patients (1997) (64)
- STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship (2016) (64)
- Contact Precautions for Preventing Nosocomial Transmission of Extended-Spectrum β Lactamase-Producing Escherichia coli: A Point/Counterpoint Review. (2017) (63)
- Risk factors and prognostic indicators of bacterial meningitis in a cohort of 3580 postneurosurgical patients. (2001) (63)
- Relative tachycardia in patients with sepsis: an independent risk factor for mortality. (2007) (63)
- The TREAT project: decision support and prediction using causal probabilistic networks. (2007) (62)
- Influx of Multidrug-Resistant, Gram-Negative Bacteria in the Hospital Setting and the Role of Elderly Patients With Bacterial Bloodstream Infection (2009) (62)
- Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. (1996) (61)
- Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. (2001) (59)
- Increased mortality among elderly patients with meticillin-resistant Staphylococcus aureus bacteraemia. (2006) (59)
- Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29] (2015) (58)
- Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex. (2008) (57)
- Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link? (2014) (56)
- Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis (2020) (55)
- Bacteremia in patients with hematological malignancies. Analysis of risk factors, etiological agents and prognostic indicators. (1997) (54)
- The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis (2007) (51)
- Key considerations on the potential impacts of the COVID-19 pandemic on antimicrobial resistance research and surveillance (2021) (51)
- Screening and isolation for infection control. (2009) (50)
- Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. (2009) (49)
- Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
- Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study (2022) (47)
- MRSA infections among patients in the emergency department: a European multicentre study (2017) (46)
- Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. (2008) (45)
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
- Candidemia in HIV-Infected Subjects (1999) (44)
- Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage (2020) (43)
- Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae (2018) (41)
- Optimising design of research to evaluate antibiotic stewardship interventions; consensus recommendations of a multinational working group. (2020) (41)
- Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. (2011) (41)
- Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and extension of hospital stay. (1998) (37)
- The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information. (2017) (37)
- HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. (2000) (37)
- BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection (2018) (36)
- Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management (2009) (36)
- Agreement among Healthcare Professionals in Ten European Countries in Diagnosing Case-Vignettes of Surgical-Site Infections (2013) (35)
- Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. (2017) (35)
- New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. (2006) (34)
- Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma (2010) (34)
- Central venous catheters and bloodstream infection. (2000) (34)
- Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. (2014) (34)
- Osteoarticular bacterial infections are rare in HIV-infected patients. 14 cases found among 4,023 HIV-infected patients. (1997) (34)
- Effect of highly active antiretroviral therapy on the incidence of bacterial pneumonia in HIV-infected subjects. (2000) (34)
- Anti-retroviral therapy with protease inhibitors decreases virulence enzyme expression in vivo by Candida albicans without selection of avirulent fungus strains or decreasing their anti-mycotic susceptibility. (2004) (33)
- A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine (2020) (33)
- Clinical Course and Long-Term Outcome of Hantavirus-Associated Nephropathia Epidemica, Germany (2015) (33)
- Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study. (1995) (33)
- Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system. (2007) (32)
- Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. (2018) (32)
- Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. (2015) (31)
- Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
- Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome. (2001) (28)
- Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. (2021) (28)
- Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors? (2019) (28)
- Pneumothorax in HIV-infected patients: role of Pneumocystis carinii pneumonia and pulmonary tuberculosis. (1997) (27)
- Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission. (2003) (27)
- HIV‐Associated Bacteremia: How It Has Changed in the Highly Active Antiretroviral Therapy (HAART) Era (2000) (27)
- Hospital-Acquired Candidemia in HIV-Infected Patients. Incidence, Risk Factors and Predictors of Outcome (2004) (27)
- Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection. (2000) (26)
- Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (24)
- Impact of Highly Active Antiretroviral Therapy (HAART) on the Incidence of Bacterial Infections in HIV-Infected Subjects (2003) (24)
- Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis (2020) (23)
- Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia - retrospective multicenter study. (2019) (23)
- Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. (1997) (23)
- Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries. (2019) (23)
- HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. (1999) (22)
- Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic (2020) (22)
- Management of obstetrics and gynaecological patients with COVID-19 (2020) (22)
- Fluconazole resistant oral candidiasis in HIV-infected patients. (1997) (22)
- Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study. (2019) (21)
- Multicentre study of antimicrobial resistance and antibiotic consumption among 6,780 patients with bloodstream infections (2006) (21)
- Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone (2017) (21)
- The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies (2006) (21)
- Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic (2021) (21)
- Staphylococcus aureus infections. (1998) (21)
- Corynebacterium striatum bacteremia in a patient with AIDS. (1994) (20)
- Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients. (2019) (20)
- Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance. (1997) (20)
- Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals. (1998) (20)
- Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis (2022) (20)
- Predictors of Staphylococcus aureus pneumonia associated with human immunodeficiency virus infection. (1996) (20)
- Participation of Elderly Adults in Randomized Controlled Trials Addressing Antibiotic Treatment of Pneumonia (2015) (20)
- Cytomegalovirus-Induced Gastrointestinal Bleeding and Pancreatitis Complicating Severe Covid-19 Pneumonia: A Paradigmatic Case (2020) (19)
- Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. (2000) (19)
- Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe (2019) (18)
- Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile (2021) (18)
- Prevalence of third-generation cephalosporin-resistant Enterobacterales colonization on hospital admission and ESBL genotype-specific risk factors: a cross-sectional study in six German university hospitals. (2020) (17)
- National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the Netherlands. (2011) (17)
- MRSA decolonization failure—are biofilms the missing link? (2017) (17)
- Changes in Incidence and Risk Factors of Mycobacterium avium Complex Infections in Patients with AIDS in the Era of New Antiretroviral Therapies (2001) (17)
- Social media posts and online search behaviour as early-warning system for MRSA outbreaks (2018) (16)
- Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes (2020) (16)
- Rapid onset of bronchiectasis in COVID-19 Pneumonia: two cases studied with CT (2020) (16)
- Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS. (1996) (15)
- Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg (2020) (15)
- Azole Susceptibility Patterns and Genetic Relationship Among Oral Candida Strains Isolated in the Era of Highly Active Antiretroviral Therapy (2002) (15)
- Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study. (2020) (15)
- Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2020) (15)
- A large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy: identifying the gaps and suggesting improvements (2016) (15)
- Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list. (2019) (15)
- Is there still a role for vancomycin in skin and soft-tissue infections? (2017) (14)
- When did the doctors become fomites? (2011) (14)
- Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. (2017) (14)
- Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. (2019) (14)
- [Infectious diseases as a clinical specialty in Germany and Europe]. (2015) (14)
- Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology. (2020) (13)
- Fighting the enemy within (2017) (13)
- Personal life and working conditions of trainees and young specialists in clinical microbiology and infectious diseases in Europe: a questionnaire survey (2017) (13)
- Vitamin D and disease severity in coronavirus disease 19 (COVID-19). (2021) (13)
- A one health framework to estimate the cost of antimicrobial resistance (2020) (13)
- Nervous system: subclinical target of SARS-CoV-2 infection (2020) (12)
- Diagnostic accuracy of point-of-care tests in acute community acquired-lower respiratory tract infections. A systematic review and meta-analysis. (2021) (12)
- Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010. (2011) (12)
- Science without meritocracy. Discrimination among European specialists in infectious diseases and clinical microbiology: a questionnaire survey (2012) (12)
- EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol (2017) (12)
- Case report: Retinopathy after malaria prophylaxis with chloroquine. (2001) (12)
- Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis (2021) (12)
- Clostridium difficile-associated diarrhea in human immunodeficiency virus infection--a changing scenario. (1999) (12)
- Antimicrobial therapy of Staphylococcus aureus bloodstream infection (2007) (12)
- Pemphigus vulgaris in a human-immunodeficiency-virus-infected patient. (1998) (11)
- Infection Risk in Sterile Operative Procedures. (2016) (11)
- Combination versus monotherapy for the treatment of infections due to carbapenem-resistant Enterobacteriaceae (2018) (11)
- Translational research strategy: an essential approach to fight the spread of antimicrobial resistance. (2014) (11)
- SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large European Multicentric Cohort of Health Workers (2022) (11)
- Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. (2021) (11)
- The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies (2021) (11)
- The Daschner Guide to In-Hospital Antibiotic Therapy 2012 – 2013. (2009) (10)
- ESCMID-an international Europe-based society committed to fostering cross-border collaboration and education to improve patient care. (2018) (10)
- P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patients. (1995) (10)
- Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit. (2018) (10)
- Risk scoring and bloodstream infections. (2007) (10)
- Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study (2012) (10)
- Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries (2020) (10)
- Role of new antibiotics for KPC-producing Klebsiella pneumoniae. (2021) (10)
- Whole-Genome Sequencing (WGS) of Carbapenem-Resistant K. pneumoniae Isolated in Long-Term Care Facilities in the Northern Italian Region (2021) (10)
- Candidiasis and HIV-Protease Inhibitors: The Expected and the Unexpected (2004) (10)
- PRAISE: providing a roadmap for automated infection surveillance in Europe. (2021) (10)
- CD16+CD56+CD8+ natural killer (NK) cells are decreased during HIV infection. (1997) (9)
- Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 (2021) (9)
- SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people (2021) (9)
- Antibiotic Stewardship 2.0 (2017) (9)
- A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency (2021) (9)
- Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group (2021) (9)
- Role of trimethoprim‐sulphamethoxazole in preventing HIV‐associated bacteraemia (1997) (9)
- A framework to develop semiautomated surveillance of surgical site infections: An international multicenter study (2019) (9)
- Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: a multicentre study promoted by the Italian Society of Infectious and Tropical Diseases. (2019) (9)
- Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide (2014) (9)
- [Central venous catheter-related sepsis: one year experience in a large university hospital] (1999) (8)
- Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (8)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (8)
- How could we reduce antibiotic use in critically ill patients? (2011) (8)
- Assessment of COVID-19 progression on day 5 from symptoms onset (2021) (8)
- Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
- Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals (2018) (8)
- The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population (2021) (8)
- Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. (2002) (8)
- Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria (2021) (8)
- Infection prevention and control in Europe - the picture in the mosaic. (2015) (8)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (8)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (7)
- Secondary Pneumocystis carinii pneumonia prophylaxis with trimethoprim-sulphamethoxazole does not prevent bacterial pneumonia in HIV-infected persons. (1996) (7)
- White Paper: Bridging the gap between human and animal surveillance data, antibiotic policy and stewardship in the hospital sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (7)
- Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern (2022) (7)
- Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission. (2017) (7)
- Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study (2020) (7)
- Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response (2022) (7)
- Age as a prognostic factor in AIDS (1996) (7)
- Correlation Between Cidofovir-Associated Uveitis and Failing Immunorestoration During HAART (2003) (7)
- Correction: Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure (2015) (7)
- Household acquisition and transmission of ESBL-producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients. (2021) (7)
- Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
- Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
- High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals (2018) (7)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (7)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (6)
- Vancomycin Way of Administration: Where is the Evidence? (2011) (6)
- Does gender affect the outcome of community-acquired Staphylococcus aureus bacteraemia? (2017) (6)
- Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries (2022) (6)
- The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. (2020) (6)
- Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region (2022) (6)
- Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review (2017) (6)
- Risk factors, nutritional status, and quality of life in HIV-infected patients with enteric salmonellosis. (1998) (6)
- Methicillin-resistant Staphylococcus aureus (MRSA) (2010) (6)
- Antimicrobial resistance rates in gram-positive bacteria do not drive glycopeptides use (2017) (6)
- Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) (2022) (6)
- Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol (2020) (6)
- Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities (2020) (6)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (6)
- In vitro susceptibility to 19 agents other than &bgr;-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission (2017) (5)
- What is the evidence base of used aggregated antibiotic resistance percentages to change empiric antibiotic treatment? A scoping review (2021) (5)
- Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy (2022) (5)
- Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort (2022) (5)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in long-term care facilities—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (5)
- ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting (2022) (5)
- Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: A multicentre European study. (2021) (5)
- The WHO Essential Medicines list AWaRe book: from a list to a quality improvement system. (2022) (5)
- Inequality dynamics in the workplace among microbiologists and infectious disease specialists: a qualitative study in five European countries. (2017) (5)
- Tuberculosis significantly reduces the survival of patients with AIDS. (1997) (5)
- Fighting antibiotic resistance all over Europe (2010) (5)
- VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment (2022) (4)
- Meticillin-resistant (MRSA): screening and decolonisation (2011) (4)
- Vancomycin-resistente Enterokokken: Welche Therapieoptionen gibt es? (2015) (4)
- Identifying risk factors for infections: the role of meta-analyses. (2009) (4)
- Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response. (2020) (4)
- Drug resistant Pseudomonas aeruginosa bacteremia in HIV-infected patients. (1995) (4)
- TREAT: a system for balancing antibiotic treatment against development of drug resistance (2004) (4)
- Meningoencephalomyelitis caused by herpes simplex virus‐1 in a patient with idiopathic T CD4+ lymphocytopenia (1998) (4)
- Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression: a prospective cohort study (2022) (3)
- Governance aspects of large-scale implementation of automated surveillance of healthcare-associated infections. (2021) (3)
- COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence (2022) (3)
- [Erratum to: Antibiotic Stewardship 2.0 : Individualization of therapy]. (2017) (3)
- New antibiotics for skin and skin-structure infections. (2014) (3)
- Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study (2019) (3)
- Beyond COVID-19—a paradigm shift in infection management? (2020) (3)
- Harmonization and standardization of data for a pan-European cohort on SARS- CoV-2 pandemic (2022) (3)
- Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study (2022) (3)
- High prevalence of Pseudomonas aeruginosa carriage in residents of French and German long-term care facilities. (2022) (3)
- Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study. (2022) (3)
- Risk perception of the antimicrobial resistance by infection control specialists in Europe: a case-vignette study (2020) (3)
- Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (2023) (3)
- The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals , 2010 and 2011 (2016) (2)
- The management of methicillin-resistant Staphylococcus aureus infection in Europe. (2010) (2)
- Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments (2022) (2)
- Treatment of the Most Frequent Types of Bacterial Endocarditis (2012) (2)
- Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine (2022) (2)
- In vivo studies on antibiotic combination for the treatment of carbapenem-resistant Gram-negative bacteria: a systematic review and meta-analysis protocol (2020) (2)
- People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission (2022) (2)
- A computerized decision support system (TREAT) to reduce inappropriate antibiotic therapy of bacterial infection (2004) (2)
- Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial (2023) (2)
- Control interventions for preventing spread of vancomycin-resistant enterococci (VRE) in hospitals (2008) (2)
- Evaluation of the scientific impact of the Ebola epidemic: a systematic review. (2017) (2)
- Microbiota-associated risk factors for C. difficile acquisition in hospitalized patients: A prospective, multicentric study. (2020) (2)
- Burden of Staphylococcus aureus endocarditis: how real is the threat? (2012) (2)
- Predictors of clinical evolution of SARS‐CoV‐2 infection in hematological patients: A systematic review and meta‐analysis (2022) (2)
- 136 – Principles of Anti-infective Therapy and Surgical Prophylaxis (2017) (2)
- The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research (2021) (2)
- Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany (2022) (2)
- [Bacterial pneumonia in HIV-infected patients] (1999) (2)
- Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp. (2022) (2)
- Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) (2020) (2)
- Resolving colistin resistance and heteroresistance in Enterobacter species (2023) (2)
- Non-AIDS-defining neoplasms and HIV infection. (1999) (2)
- Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor (2020) (1)
- Missions and Objectives of EUCIC and ESGAP (2017) (1)
- P858 Beta-lactam alone compared to β-lactam-macrolide combination therapy for community-acquired pneumonia: prospective, observational study using a propensity score (2007) (1)
- Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation (2023) (1)
- Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018. (2022) (1)
- Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study (2019) (1)
- Gram-negative bacillary meningitis in adults. (1995) (1)
- A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies (2020) (1)
- 1723P Organizational challenges and oncological activity volumes during the SARS-CoV-2 epidemic peak in Verona, Italy (2020) (1)
- The Most Common Errors in Antibiotic Therapy (2012) (1)
- [Treatment options for serious infections caused by vancomycin-resistant enterococci]. (2015) (1)
- Old and New Tools in the Diagnosis of Central Venous Catheter-Related Bloodstream Infections: Is there a Role for Brushing? (2004) (1)
- Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma (2010) (1)
- Multi-Criteria Decision Analysis to Prioritise Hospital Admission of Patients Affected by COVID-19 in Settings with Hospital-Bed Shortage (2020) (1)
- Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19–Related Disease (2021) (1)
- Aggressive versus conservative initiation of antibiotics. (2013) (1)
- Modelling and Simulation of the Effect of Targeted Decolonisation on Incidence of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections in Haematological Patients (2021) (1)
- Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial (2022) (1)
- The WHO AWaRe Antibiotic Book: providing guidance on optimal use and informing policy. (2022) (1)
- ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery. (2022) (1)
- Clinical Impact of Monoclonal Antibodies in the Treatment of High-Risk Patients with SARS-CoV-2 Breakthrough Infections: The ORCHESTRA Prospective Cohort Study (2022) (1)
- Erratum: Amplification of antimicrobial resistance in gut flora of patients treated with ceftriaxone : (Antimicrobial Agents and Chemotherapy (2018) 61: 11 (e00473-17) DOI: 10.1128/AAC.00473-17) (2018) (1)
- Fever of Unknown Origin: Differential Diagnosis (2012) (1)
- Antibiotic Therapy of the Principal Infections in Children and Adults (2012) (1)
- An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales (2020) (1)
- Classification of the Antibiotics (2012) (1)
- High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis (2022) (1)
- Association of Patients’ Epidemiological Characteristics and Comorbidities with Severity and Related Mortality Risk of SARS-CoV-2 Infection: Results of an Umbrella Systematic Review and Meta-Analysis (2022) (1)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (1)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (1)
- Antibiotic Prophylaxis for Enteryx™ Procedure: Preliminary Results (2005) (0)
- European survey on the current surveillance practices, management guidelines, treatment pathways, and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI). (2022) (0)
- Evaluating BLOOMY and SOFA scores in hospitalised patients - Authors' reply. (2022) (0)
- Clinical Impact of Antimicrobial Resistance in Hospitalized Patients: a Systematic Review (2019) (0)
- Social media posts and online search behaviour as early-warning system for MRSA outbreaks (2018) (0)
- Erratum for Meletiadis et al., “Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone” (2018) (0)
- Cardiovascular Diseases Associated Inflammatory Biomarker Levels in a Small Cohort of HIV-1 Infected Patients Deintensificated from Abacavir/Lamivudine/ Dolutegravir to Lamivudine Plus Dolutegravir Running Head: Risk of Cardiovascular Diseases and Abacavir Use (2021) (0)
- MRSA decolonization failure—are biofilms the missing link? (2017) (0)
- Prediction of bloodstream infections using TREAT: a causal probabilistic network for diagnosis and treatment of infections (2005) (0)
- Results from TREAT-WARD observational study (2004) (0)
- Quantifying antibiotic impact on within-host dynamics of extended-spectrum beta-lactamase resistance in hospitalized patients (2019) (0)
- Risk perception of antimicrobial resistance by infection control specialists in Europe: a case-vignette study (2020) (0)
- REPORT : RETINOPATHY AFTER MALARIA PROPHYLAXIS WITH CHLOROQUINE (2001) (0)
- Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases (2022) (0)
- In Reply. (2016) (0)
- The Control of MRSA (2012) (0)
- Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients (2019) (0)
- Important Infections and Their Microbiological Diagnosis (2012) (0)
- Erratum zu: Antibiotic Stewardship 2.0 (2017) (0)
- Effectiveness of antibiotic stewardship interventions in reducing the rate of colonization and infections due to antibiotic resistant bacteria and Clostridium difficile in hospital patients – a systematic review and meta-analysis Study Protocol (2017) (0)
- Linking infection control to clinical management of infections to overcome antimicrobial resistance. (2021) (0)
- Resistance of Major Clinical Pathogens (2012) (0)
- The Caliber of Segmental and Subsegmental Vessels in COVID-19 Pneumonia Is Enlarged: A Distinctive Feature in Comparison with Other Forms of Inflammatory and Thromboembolic Diseases (2020) (0)
- Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report (2019) (0)
- Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study (2023) (0)
- Diffusion of Antibiotics in Cerebrospinal Fluid and in Cerebral Abscesses (2012) (0)
- The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread (2022) (0)
- ESCMID white paper: a guide on ESCMID guidance documents. (2019) (0)
- Antibiotics in Liver Diseases (2012) (0)
- EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach (2022) (0)
- P872 BaiCD gene abundance is negatively correlated with Clostridium difficile infection (2018) (0)
- Generics and Trade Names (2009) (0)
- The severe acute respiratory syndrome coronavirus 2 pandemic puts the spotlight on gender inequality in clinical research (2021) (0)
- Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (0)
- Comprar The Daschner Guide to In-Hospital Antibiotic Therapy | Frank, Uwe | 9783540483472 | Springer (2009) (0)
- Potential for improvement in governance and national action plans to overcome antimicrobial resistance. (2023) (0)
- A Lever and a Place to Stand to Predict COVID-19 Progression: Developing a Prognostic Model Based on Day Five from Symptoms Onset (2021) (0)
- A one health framework to estimate the cost of antimicrobial resistance (2020) (0)
- Antibiotics Marketed in the EU (2012) (0)
- Antibiotic Stewardship 2.0 (2017) (0)
- The impact of a local antibiotic stewardship program: Low rate of spontaneous bacterial peritonitis and bacteriascites sustained by multidrug-resistant organisms (2021) (0)
- Antibiotic Therapy During Pregnancy and Lactation (2012) (0)
- A comparison of susceptibility to antibiotics in nosocomial and non-nosocomial infections in Israel, Germany and Italy (2006) (0)
- Antibiotics, Antimycotics: Spectrum – Dosage – Adverse Effects – Costs (2012) (0)
- Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis (2023) (0)
- Critical analysis of antibacterial agents in clinical development (2020) (0)
- Dalbavancin in the treatment of acute bacterial skin and skin structure and other infections: a safety evaluation (2022) (0)
- The multi-drug resistant organisms infections decrease during the antimicrobial stewardship era in cirrhotic patients: An Italian cohort study (2023) (0)
- TREAT: an electronic consultant for the clinical microbiologist (2004) (0)
- Introduction by Evelina Tacconelli (2017) (0)
- Clinical Efficacy of Combination Therapy for the Treatment of Severe Infections Caused by Carbapenem Resistant Gram-Negatives. A Systematic Review of Clinical Studies (2021) (0)
- Author response: Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2019) (0)
- Myocarditis in an HIV-infected patient with Covid-19. (2020) (0)
- Failure of Antibiotic Therapy (2012) (0)
- Cooperation with Microbiologists (2012) (0)
- Beta-lactam alone compared to ß-lactam-macrolide combination therapy for community-acquired pneumonia (2007) (0)
- The Most Frequent Pathogens – Choice of Antibiotics (2012) (0)
- Accessibility of covariance information creates vulnerability in Federated Learning frameworks (2023) (0)
- Hospital antimicrobial stewardship: the way forward - Authors' reply. (2017) (0)
- Identifying COVID-19 Progression by Day Five From Symptoms Onset (2021) (0)
- Mo1927 - Baicd Gene Abundance is Negatively Correlated with Clostridium Difficile Infection (2018) (0)
- Principles of Antibiotic Therapy (2012) (0)
- Minimal Duration of Treatment for Bacterial Infections (2012) (0)
- Contact precautions for the control of endemic pathogens: Finding the middle path (2023) (0)
- Prophylactic Antibiotic Therapy (2012) (0)
- A One Health Framework to Estimate Costs of Antimicrobial Resistance (2020) (0)
- Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis (2021) (0)
- Incidence of infections due to third generation cephalosporin-resistant Enterobacteriaceae - a prospective multicentre cohort study in six German university hospitals (2018) (0)
- Comprar The Daschner Guide to In-Hospital Antibiotic Therapy | Tacconelli, Evelina | 9783642184017 | Springer (2011) (0)
- Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit (2022) (0)
- The clinical and economic impact of surgical site infections after distal pancreatectomy. (2021) (0)
- Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (0)
- 3 Role of scientific societies in guidelines development. The case study of the european society of clinical microbiology and infectious diseases (2019) (0)
- New tools for antibiotic stewardship: a lesson for prescribers, researchers, or policy makers? (2022) (0)
- Evaluation of a ddPCR Commercial Assay for the Absolute Quantification of the Monkeypox Virus West Africa in Clinical Samples (2023) (0)
- Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. (2022) (0)
- The Importance of Addressing Multidrug Resistance and Not Assuming Single-Drug Resistance in Case-Control Studies (2006) (0)
- Education and training programmes for infection prevention and control professionals: mapping the current opportunities and local needs in European countries (2020) (0)
- Physical Incompatibility of Antibiotics and Antimycotics in Infusion Solutions (2012) (0)
- Impact of implementing a non-restrictive antibiotic stewardship program in an emergency department: a four-year quasi-experimental prospective study (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Evelina Tacconelli?
Evelina Tacconelli is affiliated with the following schools: